[Monogenic diabetes in children and young adults].

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nihon rinsho. Japanese journal of clinical medicine

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 22768555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.

  2006cited by this paper
• A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry.

  2006cited by this paper
• Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes.

  2006cited by this paper
• Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.

  2006cited by this paper
• Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

  2006cited by this paper
• Genetic basis of maturity-onset diabetes of the young.

  2006cited by this paper
• The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation

  2005cited by this paper
• Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.

  2005cited by this paper
• Relapsing diabetes can result from moderately activating mutations in KCNJ11.

  2005cited by this paper
• Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5.

  2005cited by this paper
• Type 2 diabetes mellitus in youth: the complete picture to date.

  2005cited by this paper
• Monogenic and other unusual causes of diabetes mellitus.

  2005cited by this paper
• High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation.

  2005cited by this paper
• Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1 Mutations

  2004cited by this paper
• First UK survey of paediatric type 2 diabetes and MODY

  2004cited by this paper
• Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations

  2004cited by this paper
• Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

  2004cited by this paper
• Clinical Course of Genetic Diseases of the Insulin Receptor (Type A and Rabson-Mendenhall Syndromes): A 30-Year Prospective

  2004cited by this paper
• Neonatal and very-early-onset diabetes mellitus.

  2004cited by this paper
• Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.

  2004cited by this paper
• Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.

  2004cited by this paper
• Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene

  2003cited by this paper
• Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.

  2003cited by this paper
• Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes.

  2003cited by this paper
• Permanent diabetes mellitus in the first year of life

  2002cited by this paper
• Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age

  2002cited by this paper
• Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

  2002cited by this paper
• Neonatal diabetes mellitus due to complete glucokinase deficiency.

  2001cited by this paper
• Maternally Inherited Diabetes and Deafness: A Multicenter Study

  2001cited by this paper
• Type 2 diabetes mellitus in UK children – an emerging problem

  2000cited by this paper
• Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes.

  2000cited by this paper
• Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor‐1α gene mutations: evidence for pharmacogenetics in diabetes

  2000cited by this paper
• An imprinted locus associated with transient neonatal diabetes mellitus.

  2000cited by this paper
• Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1.

  1999cited by this paper
• Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus

  1999cited by this paper
• Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein.

  1998cited by this paper
• A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)

  1998cited by this paper
• Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.

  1998cited by this paper
• Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1

  1997cited by this paper
• Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome.

  1995cited by this paper
• Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism.

  1993cited by this paper
• MELAS: Clinical features, biochemistry, and molecular genetics

  1992cited by this paper
• Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness

  1992cited by this paper
• Age-Corrected Empirical Genetic Risk Estimates for First-Degree Relatives of IDDM Patients

  1987cited by this paper

• ‘Diagnostiek op maat’ − de app Diabetes Diagnostics

  2018cites this paper